Non-neutralizing antibodies protect from chronic LCMV infection independently of activating FcγR or complement

European Journal of Immunology

Volumn 43, Issue 9, 2013, Pages 2349-2360

  Richter, Kirsten ^a   Oxenius, Annette ^a  

^a ETH ZURICH   (Switzerland)

Author keywords

Binding antibodies; Chronic viral infection; Fc receptors; Interleukin 10 (IL 10); LCMV

Indexed keywords

ACTIVATION INDUCED CYTIDINE DEAMINASE; ANTISERUM; ANTIVIRUS AGENT; CD40 LIGAND; FC RECEPTOR; INTERLEUKIN 10; NEUTRALIZING ANTIBODY; VIRUS ANTIBODY;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL POPULATION; COMPLEMENT ACTIVATION; CONTROLLED STUDY; CYTOKINE RELEASE; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SOMATIC HYPERMUTATION; VIRAL CLEARANCE; VIRUS INFECTION;

BINDING ANTIBODIES; CHRONIC VIRAL INFECTION; FCΓ RECEPTORS; INTERLEUKIN 10 (IL-10); LCMV;

ANIMALS; ANTIBODIES, VIRAL; B-LYMPHOCYTES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; COMPLEMENT SYSTEM PROTEINS; IMMUNOGLOBULIN CLASS SWITCHING; INTERLEUKIN-10; LYMPHOCYTIC CHORIOMENINGITIS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, CXCR5; RECEPTORS, IGG; VIRAL LOAD;

EID: 84883526486     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201343566     Document Type: Article

References (47)

1. Frebel, H., Richter, K. and Oxenius, A., How chronic viral infections impact on antigen-specific T-cell responses. Eur. J. Immunol. 2010. 40: 654-663.
2. Brooks, D. G., Trifilo, M. J., Edelmann, K. H., Teyton, L., McGavern, D. B. and Oldstone, M. B., Interleukin-10 determines viral clearance or persistence in vivo. Nat. Med. 2006. 12: 1301-1309.
3. Ejrnaes, M., Filippi, C. M., Martinic, M. M., Ling, E. M., Togher, L. M., Crotty, S. and von Herrath, M. G., Resolution of a chronic viral infection after interleukin-10 receptor blockade. J Exp Med 2006. 203: 2461-2472.
4. Clerici, M., Wynn, T. A., Berzofsky, J. A., Blatt, S. P., Hendrix, C. W., Sher, A., Coffman, R. L. et al., Role of interleukin-10 in T helper cell dysfunction in asymptomatic individuals infected with the human immunodeficiency virus. J. Clin. Invest. 1994. 93: 768-775.
5. Landay, A. L., Clerici, M., Hashemi, F., Kessler, H., Berzofsky, J. A. and Shearer, G. M., In vitro restoration of T cell immune function in human immunodeficiency virus-positive persons: effects of interleukin (IL)-12 and anti-IL-10. J. Infect. Dis. 1996. 173: 1085-1091.
6. Rigopoulou, E. I., Abbott, W. G., Haigh, P. and Naoumov, N. V., Blocking of interleukin-10 receptor-a novel approach to stimulate T-helper cell type 1 responses to hepatitis C virus. Clin. Immuno.l 2005. 117: 57-64.
7. Das, A., Ellis, G., Pallant, C., Lopes, A. R., Khanna, P., Peppa, D., Chen, A. et al., IL-10-producing regulatory B cells in the pathogenesis of chronic hepatitis B virus infection. J. Immunol. 2012. 189: 3925-3935.
8. Brooks, D. G., Teyton, L., Oldstone, M. B. and McGavern, D. B., Intrinsic functional dysregulation of CD4 T cells occurs rapidly following persistent viral infection. J. Virol. 2005. 79: 10514-10527.
9. Ng, C. T. and Oldstone, M. B., Infected CD8alpha- dendritic cells are the predominant source of IL-10 during establishment of persistent viral infection. Proc. Natl. Acad. Sci. U.S.A. 2012. 109: 14116-14121.
10. Couper, K. N., Blount, D. G. and Riley, E. M., IL-10: the master regulator of immunity to infection. J. Immunol. 2008. 180: 5771-5777.
11. Gu, H., Zou, Y. R. and Rajewsky, K., Independent control of immunoglobulin switch recombination at individual switch regions evidenced through Cre-loxP-mediated gene targeting. Cell 1993. 73: 1155-1164.
12. Senn, B. M., Lopez-Macias, C., Kalinke, U., Lamarre, A., Isibasi, A., Zinkernagel, R. M. and Hengartner, H., Combinatorial immunoglobulin light chain variability creates sufficient B cell diversity to mount protective antibody responses against pathogen infections. Eur. J. Immunol. 2003. 33: 950-961.
13. Muramatsu, M., Kinoshita, K., Fagarasan, S., Yamada, S., Shinkai, Y. and Honjo, T., Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 2000. 102: 553-563.
14. Forster, R., Mattis, A. E., Kremmer, E., Wolf, E., Brem, G. and Lipp, M., A putative chemokine receptor, BLR1, directs B cell migration to defined lymphoid organs and specific anatomic compartments of the spleen. Cell 1996. 87: 1037-1047.
15. Richter, K., Brocker, T. and Oxenius, A., Antigen amount dictates CD8(+) T-cell exhaustion during chronic viral infection irrespective of the type of antigen presenting cell. Eur. J. Immunol. 2012. 42: 2290-2304.
16. Takai, T., Li, M., Sylvestre, D., Clynes, R. and Ravetch, J. V., FcR gamma chain deletion results in pleiotrophic effector cell defects. Cell 1994. 76: 519-529.
17. Wessels, M. R., Butko, P., Ma, M., Warren, H. B., Lage, A. L. and Carroll, M. C., Studies of group B streptococcal infection in mice deficient in complement component C3 or C4 demonstrate an essential role for complement in both innate and acquired immunity. Proc. Natl. Acad. Sci. U.S.A. 1995. 92: 11490-11494.
18. Richter, K., Perriard, G. and Oxenius, A., Reversal of chronic to resolved infection by IL-10 blockade is LCMV strain dependent. Eur. J. Immunol. 2012. 43: 649-654.
19. Bergthaler, A., Flatz, L., Verschoor, A., Hegazy, A. N., Holdener, M., Fink, K., Eschli, B. et al., Impaired antibody response causes persistence of prototypic T cell-contained virus. PLoS Biol 2009. 7: e1000080.
20. Wei, X., Decker, J. M., Wang, S., Hui, H., Kappes, J. C., Wu, X., Salazar-Gonzalez, J. F. et al., Antibody neutralization and escape by HIV-1. Nature 2003. 422: 307-312.
21. Sun, P., Bauza, K., Pal, S., Liang, Z., Wu, S. J., Beckett, C., Burgess, T. et al., Infection and activation of human peripheral blood monocytes by dengue viruses through the mechanism of antibody-dependent enhancement. Virology 2011. 421: 245-252.
22. Dejnirattisai, W., Jumnainsong, A., Onsirisakul, N., Fitton, P., Vasanawathana, S., Limpitikul, W., Puttikhunt, C. et al., Cross-reacting antibodies enhance dengue virus infection in humans. Science 2010. 328: 745-748.
23. Boonnak, K., Dambach, K. M., Donofrio, G. C., Tassaneetrithep, B. and Marovich, M. A., Cell type specificity and host genetic polymorphisms influence antibody-dependent enhancement of dengue virus infection. J. Virol. 2011. 85: 1671-1683.
24. Tamura, M., Webster, R. G. and Ennis, F. A., Subtype cross-reactive, infection-enhancing antibody responses to influenza A viruses. J. Virol. 1994. 68: 3499-3504.
25. Takeda, A., Tuazon, C. U. and Ennis, F. A., Antibody-enhanced infection by HIV-1 via Fc receptor-mediated entry. Science 1988. 242: 580-583.
26. Hangartner, L., Zellweger, R. M., Giobbi, M., Weber, J., Eschli, B., McCoy, K. D., Harris, N. et al., Nonneutralizing antibodies binding to the surface glycoprotein of lymphocytic choriomeningitis virus reduce early virus spread. J. Exp. Med. 2006. 203: 2033-2042.
27. Straub, T., Schweier, O., Bruns, M., Nimmerjahn, F., Waisman, A., Pircher, H., Nucleoprotein-specific non-neutralizing antibodies speed up LCMV elimination independently of complement and FcγR. Eur. J. Immunol. 2013. 43: 2338-2348.
28. Reading, S. A. and Dimmock, N. J., Neutralization of animal virus infectivity by antibody. Arch Virol. 2007. 152: 1047-1059.
29. Mallery, D. L., McEwan, W. A., Bidgood, S. R., Towers, G. J., Johnson, C. M. and James, L. C., Antibodies mediate intracellular immunity through tripartite motif-containing 21 (TRIM21). Proc. Natl. Acad. Sci. U.S.A. 2010. 107: 19985-19990.
30. McEwan, W. A., Tam, J. C., Watkinson, R. E., Bidgood, S. R., Mallery, D. L. and James, L. C., Intracellular antibody-bound pathogens stimulate immune signaling via the Fc receptor TRIM21. Nat. Immunol. 2013. 14: 327-336.
31. Spear, G. T., Hart, M., Olinger, G. G., Hashemi, F. B. and Saifuddin, M., The role of the complement system in virus infections. Curr. Top. Microbiol. Immunol. 2001. 260: 229-245.
32. Gerhard, W., The role of the antibody response in influenza virus infection. Curr. Top. Microbiol. Immunol. 2001. 260: 171-190.
33. Pantaleo, G., Demarest, J. F., Vaccarezza, M., Graziosi, C., Bansal, G. P., Koenig, S. and Fauci, A. S., Effect of anti-V3 antibodies on cell-free and cell-to-cell human immunodeficiency virus transmission. Eur. J. Immunol. 1995. 25: 226-231.
34. Burioni, R., Williamson, R. A., Sanna, P. P., Bloom, F. E. and Burton, D. R., Recombinant human Fab to glycoprotein D neutralizes infectivity and prevents cell-to-cell transmission of herpes simplex viruses 1 and 2 in vitro. Proc. Natl. Acad. Sci. U.S.A. 1994. 91: 355-359.
35. Halstead, S. B., Mahalingam, S., Marovich, M. A., Ubol, S. and Mosser, D. M., Intrinsic antibody-dependent enhancement of microbial infection in macrophages: disease regulation by immune complexes. Lancet Infect. Dis. 2010. 10: 712-722.
36. Tamura, M., Webster, R. G. and Ennis, F. A., Antibodies to HA and NA augment uptake of influenza A viruses into cells via Fc receptor entry. Virology 1991. 182: 211-219.
37. Inada, T., Chong, K. T. and Mims, C. A., Enhancing antibodies, macrophages and virulence in mouse cytomegalovirus infection. J. Gen. Virol. 1985. 66(Pt 4): 871-878.
38. Mason, P. W., Baxt, B., Brown, F., Harber, J., Murdin, A. and Wimmer, E., Antibody-complexed foot-and-mouth disease virus, but not poliovirus, can infect normally insusceptible cells via the Fc receptor. Virology 1993. 192: 568-577.
39. Iankov, I. D., Pandey, M., Harvey, M., Griesmann, G. E., Federspiel, M. J. and Russell, S. J., Immunoglobulin g antibody-mediated enhancement of measles virus infection can bypass the protective antiviral immune response. J. Virol. 2006. 80: 8530-8540.
40. Kishimoto, C., Kurokawa, M. and Ochiai, H., Antibody-mediated immune enhancement in coxsackievirus B3 myocarditis. J. Mol. Cell. Cardiol. 2002. 34: 1227-1238.
41. Mahalingam, S. and Lidbury, B. A., Suppression of lipopolysaccharide-induced antiviral transcription factor (STAT-1 and NF-kappa B) complexes by antibody-dependent enhancement of macrophage infection by Ross River virus. Proc. Natl. Acad. Sci. U.S.A. 2002. 99: 13819-13824.
42. van Montfoort, N., Mangsbo, S. M., Camps, M. G., van Maren, W. W., Verhaart, I. E., Waisman, A., Drijfhout, J. W. et al., Circulating specific antibodies enhance systemic cross-priming by delivery of complexed antigen to dendritic cells in vivo. Eur. J. Immunol. 2012. 42: 598-606.
43. Richter, K., Agnellini, P. and Oxenius, A., On the role of the inhibitory receptor LAG-3 in acute and chronic LCMV infection. Int. Immunol. 2010. 22: 13-23.
44. Kuhn, R., Lohler, J., Rennick, D., Rajewsky, K. and Muller, W., Interleukin-10-deficient mice develop chronic enterocolitis. Cell 1993. 75: 263-274.
45. Kawabe, T., Naka, T., Yoshida, K., Tanaka, T., Fujiwara, H., Suematsu, S., Yoshida, N. et al., The immune responses in CD40-deficient mice: impaired immunoglobulin class switching and germinal center formation. Immunity 1994. 1: 167-178.
46. Eschli, B., Zellweger, R. M., Wepf, A., Lang, K. S., Quirin, K., Weber, J., Zinkernagel, R. M. et al., Early antibodies specific for the neutralizing epitope on the receptor binding subunit of the lymphocytic choriomeningitis virus glycoprotein fail to neutralize the virus. J. Virol. 2007. 81: 11650-11657.
47. Battegay, M., Cooper, S., Althage, A., Banziger, J., Hengartner, H. and Zinkernagel, R. M., Quantification of lymphocytic choriomeningitis virus with an immunological focus assay in 24- or 96-well plates. J. Virol. Methods 1991. 33: 191-198.